Cargando…

β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies

Cardiovascular disease (CVD) remains a major problem for people with type 2 diabetes mellitus (T2DM), and dyslipidemia is one of the main drivers for both metabolic diseases. In this review, the major pathophysiological and molecular mechanisms of β-cell dysfunction and recovery in T2DM are discusse...

Descripción completa

Detalles Bibliográficos
Autor principal:	Al-Mrabeh, Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927138/ https://www.ncbi.nlm.nih.gov/pubmed/33672162 http://dx.doi.org/10.3390/biomedicines9020226

Ejemplares similares

Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss
por: Jesuthasan, Aaron, et al.
Publicado: (2021)

Effect of Weight Loss by Low-Calorie Diet on Cardiovascular Health in Type 2 Diabetes: An Interventional Cohort Study
por: Melhem, Shaden, et al.
Publicado: (2021)

Measurement of intraorgan fat and hepatic output of triglycerides in human type 2 diabetes by magnetic resonance and intralipid infusion techniques
por: Al-Mrabeh, Ahmad, et al.
Publicado: (2021)

Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease
por: Cojocaru, Karina-Alexandra, et al.
Publicado: (2023)

Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity
por: Al-Mrabeh, Ahmad, et al.
Publicado: (2016)

Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics
por: Dong, Yunzhou, et al.
Publicado: (2016)

Lipid metabolism in cancer progression and therapeutic strategies
por: Fu, Yan, et al.
Publicado: (2020)

Quantification of intrapancreatic fat in type 2 diabetes by MRI
por: Al-Mrabeh, Ahmad, et al.
Publicado: (2017)

Progress in therapeutic strategies based on cancer lipid metabolism
por: Diao, Xia‐Yao, et al.
Publicado: (2019)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
por: Huang, Xiaoyang, et al.
Publicado: (2022)

Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39:808–815
por: Steven, Sarah, et al.
Publicado: (2018)

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort
por: Taylor, Roy, et al.
Publicado: (2017)

Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes
por: Dalle, Stéphane, et al.
Publicado: (2023)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Cardiovascular and autonomic dysfunction in long-COVID syndrome and the potential role of non-invasive therapeutic strategies on cardiovascular outcomes
por: Allendes, Francisca J., et al.
Publicado: (2023)

The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis
por: Xiao, Fengyan, et al.
Publicado: (2020)

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
por: Mashek, Douglas G.
Publicado: (2020)

Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
por: Campos-Peña, Victoria, et al.
Publicado: (2022)

Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
por: Jo, Sugyeong, et al.
Publicado: (2021)

β-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes
por: Shi, Chang-Xiang, et al.
Publicado: (2016)

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases
por: Liu, Yu, et al.
Publicado: (2022)

Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations
por: Chen, Chuck T., et al.
Publicado: (2022)

Ectopic lipid metabolism in anterior pituitary dysfunction
por: Baumgartner, Clemens, et al.
Publicado: (2023)

ER stress and hepatic lipid metabolism
por: Zhou, Huiping, et al.
Publicado: (2014)

SIRT7 and hepatic lipid metabolism
por: Tang, Bor Luen
Publicado: (2015)

Editorial: Hepatic glucose and lipid metabolism
por: Zhang, Huabing, et al.
Publicado: (2022)

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease
por: Wang, Xueliang, et al.
Publicado: (2022)

Yeast β‐Glucan Improves Insulin Sensitivity and Hepatic Lipid Metabolism in Mice Humanized with Obese Type 2 Diabetic Gut Microbiota
por: Mitchelson, Kathleen A. J., et al.
Publicado: (2022)

Innovative therapeutic strategies for cardiovascular disease
por: Maiese, Kenneth
Publicado: (2023)

β-Cell Succinate Dehydrogenase Deficiency Triggers Metabolic Dysfunction and Insulinopenic Diabetes
por: Lee, Sooyeon, et al.
Publicado: (2022)

Lipid Metabolism as a Therapeutic Target
por: Smith, Terry K., et al.
Publicado: (2012)

Metabolically Healthy Obesity (MHO)—New Research Directions for Personalised Medicine in Cardiovascular Prevention
por: Nilsson, Peter M., et al.
Publicado: (2020)

Possibility of a New Therapeutic Strategy for Left Ventricular Dysfunction in Type 2 Diabetes
por: Sakamoto, Masaya, et al.
Publicado: (2018)

New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions
por: Guo, Bei, et al.
Publicado: (2020)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
por: Huang, Yafei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8npfaar5ho5fm0cfnl8fqvvbf8